Gleevec (imatinib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has tried at least one medication such as liposomal doxorubicin, paclitaxel, pomalidomide, lenalidomide, etoposide, or thalidomide
• Patient has relapsed or refractory disease

Approval duration

1 year